Regulatory report: delta-8 THC in the US 

The emergence of delta-8 THC has divided opinion within the industry, but the high-inducing cannabinoid is nonetheless being sold widely across the US due to the legal uncertainty around it. So how can delta-8 THC – which undoubtedly has psychoactive effects when consumed – be sold so openly, especially in states that do not allow cannabis sales? The simplest answer is that delta-8 is surviving – even thriving – in a legal grey area created by the 2018 US Farm Bill.

This report examines federal law on delta-8, notes trends that are happening at state level, and discusses what the future may hold.

Free Sample
I'm already a subscriber

Anthony Traurig

Senior advisor
Anthony is senior advisor to CannIntelligence, where he provides regulatory guidance on issues within the global cannabis sector. Having worked several years as a legal analyst at CannIntelligence, he continues to work on consultancy projects and contribute to regulatory products for the platform. Anthony has a BA in political science from North Carolina State University and a Juris Doctor from Charleston School of Law (South Carolina), and practised law for several years in the United States as a litigator.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization